Abstract
Women with chronic hypertension and pregnancy-induced hypertension are at substantial risk for developing preeclampsia/ eclampsia, a disease with high fetomaternal morbidity and mortality. However, the etiology of this disease is still unknown. In this article, recent concepts on the pathophysiology of pre-eclampsia, with special attention to the role of nitric oxide, are reviewed.
Similar content being viewed by others
References and Recommended Reading
Roberts JM, Pearson G, Cutler J, et al.: Summary of the NHLBI Working Group on Research on Hypertension During Pregnancy. Hypertension 2003, 41:437–45. Consensus on classification of hypertensive disorders of pregnancy and summary of recent insights into the pathophysiology of preeclampsia.
Sibai BM: Chronic hypertension in pregnancy. Obstet Gynecol 2002, 100:369–377.
Brown MA, Lindheimer MD, de Swiet M, et al.: The classification and diagnosis of the hypertensive disorders of pregnancy: statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregn 2001, 20:IX-XIV.
Hallak M: Hypertension in pregnancy. In High Risk Pregnancy. Management Options. Edited by James DK, Steer PJ, Weiner CP, et al. Philadelphia: WB Saunders; 1999:639–663.
Zhang J, Klebanoff MA, Roberts JM: Prediction of adverse outcomes by common definitions of hypertension in pregnancy. Obstet Gynecol 2001, 97:261–267.
Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000, 183:S1–S22.
Sibai BM, Gordon T, Thom E, et al.: Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995, 172:642–648.
Seligman S: Which blood pressure? Br J Obstet Gynaecol 1987, 94:497–498.
Weinstein L: Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 1982, 142:159–167.
Sibai BM: The HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): much ado about nothing? Am J Obstet Gynecol 1990, 162:311–316.
Shembrey MA, Noble AD: An instructive case of abdominal pregnancy. Aust N Z J Obstet Gynaecol 1995, 35:220–221.
Page E: The relation between hydatidiform moles, relative ischemia of the gravid uterus, and the placental origin of eclampsia. Am J Obstet Gynecol 1939, 37:291–293.
Roberts JM, Lain KY: Recent insights into the pathogenesis of pre-eclampsia. Placenta 2002, 23:359–372.
Baylis C, Beinder E, Suto T, et al.: Recent insights into the roles of nitric oxide and renin-angiotensin in the pathophysiology of preeclamptic pregnancy. Semin Nephrol 1998, 18:208–230. A comprehensive overview on recent study results regarding the role of NO in normal and pre-eclamptic pregnancy.
Scalera F, Schlembach D, Beinder E: Production of vasoactive substances by human umbilical vein endothelial cells after incubation with serum from preeclamptic patients. Eur J Obstet Gynecol Reprod Biol 2001, 99:172–178.
Savvidou MD, Hingorani A, Tsikas D, et al.: Endothelial dysfunction and raised plasma concentrations of asymmetric dimethylarginine in pregnant women who subsequently develop pre-eclampsia. Lancet 2003, 361:1511–17. Important study demonstrating the correlation between NO deficiency and disturbed maternofetal circulation.
Clark SL, Cotton DB, Lee W, et al.: Central hemodynamic assessment of normal term pregnancy. Am J Obstet Gynecol 1989, 161:1439–1442.
Roberts M, Lindeheimer MD, Davison JM: Altered glomerular permselectivity to neutral dextrans and heteroporous membrane modeling in human pregnancy. Am J Physiol 1996, 270(2Pt2):F338-F343.
Baylis C: Glomerular filtration and volume regulation in gravid animal models. Bailliere’s Clin Obstet Gynaecol 1994, 8:235–264.
Cotton D, Lee W, Huhta J, et al.: Hemodynamic profile of severe pregnancy-induced hypertension. Am J Obstet Gynecol 1988, 158:523–529.
Groenendijk R, Trimbos JB, Wallenburg HC: Hemodynamic measurements in preeclampsia: preliminary observations. Am J Obstet Gynecol 1984, 150:232–236.
Brown M, Zammit V, Mitar D: Extracellular fluid volume in pregnancy-induced hypertension. J Hypertens 1992, 10:61–68.
Zhou Y, Damsky CH, Fisher SJ: Preeclampsia is associated with failure of human cytotrophoblasts to mimic a vascular adhesion phenotype: one cause of defective endovascular invasion in this syndrome? J Clin Invest 1997, 99:2152–2164.
Reister F, Frank HG, Kingdom JC, et al.: Macrophage-induced apoptosis limits endovascular trophoblast invasion in the uterine wall of preeclamptic women. Lab Invest 2001, 81:1143–1152.
Taylor RN, Grimwood J, Taylor RS, et al.: Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. Am J Obstet Gynecol 2003, 188:177–182.
Genbacev O, Zhou Y, Ludlow JW, et al.: Regulation of human placental development by oxygen tension. Science 1997, 277:1669–1672. The impact of oxygen tension on the proliferative capacity of cytotrophoblasts is demonstrated.
Kashiwagi M, Breymann C, Huch R, et al.: Hypertension in a pregnancy with renal anemia after recombinant human erythropoietin (rhEPO) therapy. Arch Gynecol Obstet 2002, 267:54–56.
Ong SS, Crocker IP, Warren AY, et al.: Functional characteristics of chorionic plate placental arteries from normal pregnant women and women with pre-eclampsia. Hypertens Pregnancy 2002, 21:175–183.
King RG, Gude NM, Di Iulio JL, et al.: Regulation of human placental fetal vessel tone: role of nitric oxide. Reprod Fertil Dev 1995, 7:1407–1411.
Walsh SW: Preeclampsia: an imbalance in placental prostacyclin and thromboxane production. Am J Obstet Gynecol 1985, 152:335–340.
Chavarria ME, Lara-Gonzalez L, Gonzalez-Gleason A, et al.:Prostacyclin/thromboxane early changes in pregnancies that are complicated by preeclampsia. Am J Obstet Gynecol 2003, 188:986–992.
Scalera F, Dittrich R, Beckmann MW, et al.: Effect of endothelin-1 on intracellular glutathione and lipid peroxide availability and on the secretion of vasoactive substances by human umbilical vein endothelial cells. Eur J Clin Invest 2002, 32:556–562.
Cockell AP, Poston L: Flow-mediated vasodilatation is enhanced in normal pregnancy but reduced in preeclampsia. Hypertension 1997, 30:247–251.
Li H, Wallerath T, Forstermann U: Physiological mechanisms regulating the expression of endothelial-type NO synthase. Nitric Oxide 2002, 7:132–147.
Sladek SM, Magness RR, Conrad KP: Nitric oxide and pregnancy. Am J Physiol 1997, 272:R441-R463.
Seligman SP, Buyon JP, Clancy RM, et al.: The role of nitric oxide in the pathogenesis of preeclampsia. Am J Obstet Gynecol 1994, 171:944–948.
Williams DJ, Vallance PJ, Neild GH, et al.: Nitric oxide-mediated vasodilation in human pregnancy. Am J Physiol 1997, 272:H748-H752.
Conrad KP, Joffe GM, Kruszyna H, et al.: Identification of increased nitric oxide biosynthesis during pregnancy in rats. FASEB J 1993, 7:566–571.
Myatt L, Brewer AS, Langdon G, et al.: Attenuation of the vasoconstrictor effects of thromboxane and endothelin by nitric oxide in the human fetal-placental circulation. Am J Obstet Gynecol 1992, 166:224–230.
Cadnapaphornchai MA, Ohara M, Morris KG Jr, et al.: Chronic NOS inhibition reverses systemic vasodilation and glomerular hyperfiltration in pregnancy. Am J Physiol Renal Physiol 2001, 280:F592-F598.
Diket AL, Pierce MR, Munshi UK, et al.: Nitric oxide inhibition causes intrauterine growth retardation and hind-limb disruptions in rats. Am J Obstet Gynecol 1994, 171:1243–1250.
Yallampalli C, Garfield RE: Inhibition of nitric oxide synthesis in rats during pregnancy produces signs similar to those of preeclampsia. Am J Obstet Gynecol 1993, 169:1316–1320. This article reveals a possible correlation between NO deficiency and pre-eclampsia.
Salas SP, Altermatt F, Campos M, et al.: Effects of long-term nitric oxide synthesis inhibition on plasma volume expansion and fetal growth in the pregnant rat. Hypertension 1995, 26:1019–1023. This study provided additional evidence for a correlation between NO deficiency and fetal intrauterine growth retardation, which is a common feature in early-onset pre-eclampsia.
Molnar M, Suto T, Toth T, et al.: Prolonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, proteinuria, thrombocytopenia, and intrauterine growth retardation. Am J Obstet Gynecol 1994, 170:1458–1466.
Ramsay B, Sooranna SR, Johnson MR: Nitric oxide synthase activities in human myometrium and villous trophoblast throughout pregnancy. Obstet Gynecol 1996, 87:249–253.
Beinder E, Mohaupt MG, Schlembach D, et al.: Nitric oxide synthase activity and Doppler parameters in the fetoplacental and uteroplacental circulation in preeclampsia. Hypertens Pregn 1999, 18:115–127.
Shaamash AH, Elsnosy ED, Makhlouf AM, et al.: Maternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsia. Int J Gynaecol Obstet 2000, 68:207–214.
Rajagopal M, Moodley J, Chetty R: Nitric oxide: Does it have an etiological role in pre-eclampsia? Acta Obstet Gynecol Scand 2003, 82:216–219.
Nakatsuka M, Takata M, Tada K, et al.: A long-term transdermal nitric oxide donor improves uteroplacental circulation in women with preeclampsia. J Ultrasound Med 2002, 21:831–836.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kashiwagi, M., Zimmermann, R. & Beinder, E. Pathophysiology of pre-eclampsia: Update on the role of nitric oxide. Current Science Inc 5, 493–497 (2003). https://doi.org/10.1007/s11906-003-0057-2
Issue Date:
DOI: https://doi.org/10.1007/s11906-003-0057-2